Cytokinetics (CYTK): Siren, L.L.C. exited its position 402K shares
Siren, L.L.C. exited its position in Cytokinetics, per its Q1 2025 13F.
- 402K
- Prior-quarter shares · no longer reported
- Holdings as of
- Mar 31, 2025
- Filed
- May 23, 2025
What stands out in this filing
- The manager reported no shares in Q1 2025, after 402,323 in its Q4 2024 filing.
- 1 other tracked manager reported the same kind of change for Q1 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 31, 2025InsiderCEO sold ~$611K of CYTK shares in the open market
- Apr 3, 2025InsiderDirector sold ~$18K of CYTK shares in the open market
- Apr 7, 2025InsiderOfficer sold ~$103K of CYTK shares in the open market
- Apr 8, 2025InsiderOfficer sold ~$72K of CYTK shares in the open market
- Apr 10, 2025InsiderCEO sold ~$184K of CYTK shares in the open market
- Apr 15, 2025InsiderDirector sold ~$123K of CYTK shares in the open market
- Apr 21, 2025InsiderDirector sold ~$769K of CYTK shares in the open market
- Apr 22, 2025InsiderOfficer sold ~$76K of CYTK shares in the open market
- Apr 29, 2025InsiderCEO sold ~$205K of CYTK shares in the open market
- May 5, 2025InsiderOfficer sold ~$147K of CYTK shares in the open market
- May 6, 2025InsiderOfficer sold ~$70K of CYTK shares in the open market
- May 15, 2025InsiderDirector sold ~$43K of CYTK shares in the open market
- May 16, 2025InsiderCEO sold ~$155K of CYTK shares in the open market
- May 20, 2025InsiderOfficer sold ~$64K of CYTK shares in the open market
What came next
- Jun 2, 2025InsiderCEO sold ~$156K of CYTK shares in the open market
- Jun 3, 2025InsiderOfficer sold ~$64K of CYTK shares in the open market
- Jun 5, 2025Insider · 2 peopleInsiders: 2 sales (~$394K)
- Jun 11, 2025CongressDisclosed purchase of CYTK — reported range $1,001 - $15,000
- Jun 16, 2025InsiderCEO sold ~$169K of CYTK shares in the open market
- Jun 17, 2025InsiderOfficer sold ~$66K of CYTK shares in the open market
- Jun 17, 2025CongressDisclosed sale of CYTK — reported range $1,001 - $15,000
- Jul 1, 2025InsiderCEO sold ~$168K of CYTK shares in the open market
- Jul 8, 2025InsiderOfficer sold ~$68K of CYTK shares in the open market
- Jul 14, 2025InsiderCEO sold ~$191K of CYTK shares in the open market
- Jul 22, 2025InsiderOfficer sold ~$75K of CYTK shares in the open market
- Jul 29, 2025InsiderCEO sold ~$182K of CYTK shares in the open market
- Aug 5, 2025InsiderOfficer sold ~$73K of CYTK shares in the open market
- Aug 15, 2025InsiderCEO sold ~$192K of CYTK shares in the open market
- Aug 19, 2025InsiderOfficer sold ~$77K of CYTK shares in the open market
- Sep 2, 2025Insider · 3 peopleInsiders: 3 sales (~$686K)
- Sep 9, 2025InsiderOfficer sold ~$103K of CYTK shares in the open market
- Sep 15, 2025InsiderCEO sold ~$249K of CYTK shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Cytokinetics
For Cytokinetics, OQRO holds 26 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.
How this filing works
Explore the data
Common questions
What does this filing report about Cytokinetics (CYTK) stock?
Siren, L.L.C. exited its position in Cytokinetics, per its Q1 2025 13F. Held the prior quarter, no longer listed per its Q1 2025 13F.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2025. Filed: May 23, 2025.
What stands out in this filing?
The manager reported no shares in Q1 2025, after 402,323 in its Q4 2024 filing. 1 other tracked manager reported the same kind of change for Q1 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Cytokinetics recently?
For Cytokinetics, OQRO holds 26 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days. They are listed on the CYTK page.
Does this mean CYTK stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Cytokinetics
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 19, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
Everything OQRO holds on this company is on its CYTK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
